Detailed information for compound 105908
Basic information
Technical information
- Name: Unnamed compound
- MW: 432.741 | Formula: C20H19BrClN3O
-
H donors: 0
H acceptors: 2
LogP: 5.13
Rotable bonds: 3
Rule of 5 violations (Lipinski): 1 - SMILES: CN1CC[C@H]([C@@H](C1)c1onc(n1)c1ccc(cc1)Br)c1ccc(cc1)Cl
- InChi: 1S/C20H19BrClN3O/c1-25-11-10-17(13-4-8-16(22)9-5-13)18(12-25)20-23-19(24-26-20)14-2-6-15(21)7-3-14/h2-9,17-18H,10-12H2,1H3/t17-,18+/m0/s1
- InChiKey: VGTHXWPAVSKNJJ-ZWKOTPCHSA-N
Network
Hover on a compound node to display the structore
Synonyms
No synonyms found for this compound
Targets
Known targets for this compound
| Species | Target name | Source | Bibliographic reference |
|---|---|---|---|
| Rattus norvegicus | Dopamine transporter | Starlite/ChEMBL | References |
| Rattus norvegicus | Norepinephrine transporter | Starlite/ChEMBL | References |
| Rattus norvegicus | Serotonin transporter | Starlite/ChEMBL | References |
Predicted pathogen targets for this compound
By orthology
By sequence similarity to non orthologous known druggable targets
Obtained from network model
Ranking Plot
Putative Targets List
| Species | Potential target | Raw | Global | Species |
|---|---|---|---|---|
| Echinococcus granulosus | solute carrier family 5 | 0.0328 | 1 | 1 |
| Schistosoma mansoni | inositol transporter | 0.0328 | 1 | 1 |
| Echinococcus granulosus | sodium:myo inositol cotransporter | 0.0328 | 1 | 1 |
| Loa Loa (eye worm) | serotonin transporter b | 0.0292 | 0 | 0.5 |
| Schistosoma mansoni | inositol transporter | 0.0328 | 1 | 1 |
| Echinococcus multilocularis | sodium:myo inositol cotransporter | 0.0328 | 1 | 1 |
| Loa Loa (eye worm) | hypothetical protein | 0.0292 | 0 | 0.5 |
| Brugia malayi | Sodium:neurotransmitter symporter family protein | 0.0292 | 0 | 0.5 |
| Treponema pallidum | sodium- and chloride- dependent transporter | 0.0292 | 0 | 0.5 |
| Loa Loa (eye worm) | norepinephrine transporter | 0.0292 | 0 | 0.5 |
| Loa Loa (eye worm) | solute carrier family 6 member 4 | 0.0292 | 0 | 0.5 |
| Echinococcus multilocularis | sodium:glucose cotransporter 2 | 0.0328 | 1 | 1 |
| Onchocerca volvulus | 0.0292 | 0 | 0.5 | |
| Loa Loa (eye worm) | hypothetical protein | 0.0292 | 0 | 0.5 |
| Loa Loa (eye worm) | hypothetical protein | 0.0292 | 0 | 0.5 |
| Echinococcus granulosus | sodium:glucose cotransporter 2 | 0.0328 | 1 | 1 |
| Echinococcus multilocularis | solute carrier family 5 | 0.0328 | 1 | 1 |
Activities
| Activity type | Activity value | Assay description | Source | Reference |
|---|---|---|---|---|
| Ki (binding) | > 3000 nM | Displacement of [3H]-WIN- 35248 from dopamine transporter (DAT) of rat striatal membrane | ChEMBL. | 11514143 |
| Ki (binding) | > 3000 nM | Inhibition of high affinity uptake of [3H]-DA using rat nerve endings obtained from brain regions enriched in DAT. | ChEMBL. | 11514143 |
| Ki (binding) | > 3000 nM | Displacement of [3H]-5-HT from serotonin transporter of rat brain | ChEMBL. | 11514143 |
| Ki (binding) | > 3000 nM | Displacement of [3H]-NE from Norepinephrine transporter of rat brain | ChEMBL. | 11514143 |
| Ki (binding) | > 3000 nM | Displacement of [3H]-WIN- 35248 from dopamine transporter (DAT) of rat striatal membrane | ChEMBL. | 11514143 |
| Ki (binding) | > 3000 nM | Inhibition of high affinity uptake of [3H]-DA using rat nerve endings obtained from brain regions enriched in DAT. | ChEMBL. | 11514143 |
| Ki (binding) | > 3000 nM | Displacement of [3H]-5-HT from serotonin transporter of rat brain | ChEMBL. | 11514143 |
| Ki (binding) | > 3000 nM | Displacement of [3H]-NE from Norepinephrine transporter of rat brain | ChEMBL. | 11514143 |
Phenotypes
Whole-cell/tissue/organism interactions
We have no records of whole-cell/tissue assays done with this compound
What does this mean?
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
Annotated phenotypes:
We have no manually annotated phenotypes for this drug.
What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by
drugs, or by genetic manipulation of cells (e.g. gene knockouts or
knockdowns) is manually curated from the literature. These
descriptions help to describe the potential of the target for drug
development. If no information is available for this gene or if the
information is incomplete, this may mean that i) the papers
containing this information either appeared after the curation
effort for this organism was carried out or they were inadvertently
missed by curators; or that ii) the curation effort for this
organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.
External resources for this compound
- ChEMBL: CHEMBL411947
Bibliographic References
1 literature reference was collected for this gene.
If you have references for this compound, please enter them in a user comment (below) or Contact us.